🔎 Trials Near Me

홈 › 두경부 편평세포암 › 미시간

미시간의 두경부 편평세포암 임상 시험

두경부 편평세포암 관련 연구 35개가 미시간 내 여러 지역에서 참여자를 모집하고 있습니다.

미시간의 도시

공식 연구 텍스트(영어)

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

  • ALX Center 8, Farmington Hills
  • ALX Center 3, Grand Rapids
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07085091

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
  • Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
  • 외 8개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06589804

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

  • BAMF Health, Grand Rapids
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07189871

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

  • Trinity Health St Joseph Mercy Ann Arbor, Ann Arbor
  • Karmanos Cancer Institute, Detroit
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07276399

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Karmanos Cancer Institute, Detroit
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06385080

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Bronson Battle Creek, Battle Creek
  • 외 23개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05136196

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

  • START Midwest, Grand Rapids
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT05267626

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • Cancer & Hematology Centers of Western Michigan, Grand Rapids
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT05059444

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

  • MyMichigan Medical Center Gratiot, Alma
  • MyMichigan Medical Center Alpena, Alpena
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • 외 60개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT02734537

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06465069

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

  • Henry Ford, Detriot
  • Karmanos Cancer Institute, Detroit
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06163534

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

  • Henry Ford Cancer Institute/Henry Ford Health System, Detroit
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT06769698

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

  • Research Site, Grand Rapids
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT07115043

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

  • McLaren Cancer Institute-Bay City, Bay City
  • McLaren Cancer Institute-Clarkston, Clarkston
  • Wayne State University/Karmanos Cancer Institute, Detroit
  • 외 8개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT06532279

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Wayne State University/Karmanos Cancer Institute, Detroit
  • Henry Ford Hospital, Detroit
  • 외 3개
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT04333537

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

  • START Midwest, Grand Rapids
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 13. 업데이트됨 · NCT05985655

A Study of MGC026 in Participants With Advanced Solid Tumors

  • START Midwest, Grand Rapids
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT06242470

A Study of DM005 in Patients With Advanced Solid Tumors

  • Henry Ford Cancer Institute, Detroit
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT06515990

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #65, Detroit
  • Exelixis Clinical Site #13, Detroit
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT05176483

Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial

  • University of Michigan Comprehensive Cancer Center, Ann Arbor
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 31. 업데이트됨 · NCT07121595

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • Henry Ford Cancer Institute, Detroit
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT04198766

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

  • Karmanos Cancer Institute, Detroit
  • Karmanos Cancer Institute, Farmington Hills
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT05208762

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • START Midwest, Grand Rapids
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 7. 업데이트됨 · NCT05768139

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

  • Karmanos Cancer Institute, Detroit
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 18. 업데이트됨 · NCT07503808

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

  • University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 4. 업데이트됨 · NCT04777994

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

  • Henry Ford Health System, Detroit
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 4. 6. 업데이트됨 · NCT05785741

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

  • START Midwest, Grand Rapids
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 2. 18. 업데이트됨 · NCT07030257

A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)

  • University of Michigan Rogel Cancer Center, Ann Arbor
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 2. 2. 업데이트됨 · NCT05894083

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

  • START Midwest, Grand Rapids
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 12. 11. 업데이트됨 · NCT06943521

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

  • Research Site 129, Detroit
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 11. 21. 업데이트됨 · NCT05914116

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

  • University of Michigan, Ann Arbor
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 11. 4. 업데이트됨 · NCT05902988

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

  • University of Michigan, Ann Arbor
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 9. 24. 업데이트됨 · NCT05941507

A Beta-only IL-2 ImmunoTherapY Study

  • Karmanos Cancer Institute, Detroit
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 7. 9. 업데이트됨 · NCT05086692

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.